Inhibiting mPTP opening has been proposed as a neuroprotective strategy for a number of neurodegenerative diseases (Rao et al., 2014), and one proposed mechanism for SIRT3-mediated cytoprotection involves it inhibiting the opening of the mPTP (Hafner et al., 2010). This evidence concerns the gene SIRT3 and neurodegenerative disease.